Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33560
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOvchinnikov, D A-
dc.contributor.authorJong, S-
dc.contributor.authorCuddy, C-
dc.contributor.authorScheffer, Ingrid E-
dc.contributor.authorMaljevic, S-
dc.contributor.authorPetrou, S-
dc.date2023-
dc.date.accessioned2023-08-23T07:20:01Z-
dc.date.available2023-08-23T07:20:01Z-
dc.date.issued2023-08-08-
dc.identifier.citationStem Cell Research 2023-08-08; 71en_US
dc.identifier.issn1876-7753-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/33560-
dc.description.abstractA range of epilepsies, including the most severe group of developmental and epileptic encephalopathies (DEEs), are caused by gain-of-function variants in voltage-gated channels. Here we report the generation and characterisation of an iPSC cell line from the fibroblasts of a girl with early infantile DEE carrying heterozygous missense gain-of-function mutation (R1882Q) in Nav1.2(SCN2A) protein, using transient transfection with a single mRNA molecule. The established iPSC line displays typical human primed pluripotent stem cell characteristics: typical colony morphology and robust expression of pluripotency-associated marker genes, ability to give rise to derivatives of all three embryonic germ layers, and normal karyotype without any SNP array-detectable copy number variations. We anticipate that this iPSC line will be useful for the development of neuronal hyperactivity-caused human stem cell-based DEE models, advancing both understanding and potential therapy development for this debilitating condition.en_US
dc.language.isoeng-
dc.titleGeneration of an iPSC line (FINi001-A) from a girl with developmental and epileptic encephalopathy due to a heterozygous gain-of-function p.R1882Q variant in the voltage-gated sodium channel Nav1.2 protein encoded by the SCN2A gene.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleStem Cell Researchen_US
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen_US
dc.identifier.affiliationPaediatricsen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.affiliationRoyal Children's Hospital, Murdoch Children's Research Institute, Melbourne, VIC, Australiaen_US
dc.identifier.affiliationPraxis Precision Medicines, Cambridge, MA, USAen_US
dc.identifier.doi10.1016/j.scr.2023.103179en_US
dc.type.contentTexten_US
dc.identifier.pubmedid37597357-
dc.description.volume71-
dc.description.startpage103179-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptEpilepsy Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

36
checked on Nov 20, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.